Court of Appeals Rejects Overturn of $12.8 Million Verdict
Court of Appeals Rejects Overturn of $12.8 Million Verdict

Introduction
A state appeals court panel rejected the proposal to overturn a $12.8 million verdict against Johnson & Johnson's subsidiary Ethicon Inc. over their surgical mesh implant lawsuit filed by a plaintiff. Judge Victor P. Stabile confirmed Ethicon is liable to pay the damages to the woman for her post-surgery complications.
In 2009, the plaintiff underwent surgery to implant Ethicon Prolift Kit mesh in her body. The defective design of the mesh left her with serious problems including chronic vaginal pain during sexual intercourse and vaginal mesh erosion, requiring three corrective surgeries. She filed a product liability lawsuit in 2013 against Ethicon for failing to warn the doctors about the potential risks of the mesh. Judge Stabile rejected the manufacturer's claim that Pennsylvania courts don't have jurisdiction in the case, and that the evidence does not support the damage verdict.
Several women across the U.S. who implanted transvaginal mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) claim about the inadequate warning from the mesh makers. More than 100,000 transvaginal mesh lawsuits are federally-filed against various manufacturers. Ethicon Hernia Mesh lawsuits are consolidated as a part of multidistrict litigation (MDL No.2782; In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation) before U.S. District Judge Richard Story in the Northern District of Georgia.
Latest News
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…
Tepezza Hearing Loss Trials Delayed Until Aug 2026
A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…